Latest David Samadi Stories
NEW YORK, Aug. 13, 2011 /PRNewswire/ -- Robotics are helping surgeons make great strides in the medical arena, and the advanced technology used in robotic prostatectomy procedures delivers many benefits to both surgeon and patient.
NEW YORK, Aug. 12, 2011 /PRNewswire/ -- Prostate Specific Antigen (PSA) screening is the universal standard for early detection of prostate cancer in men.
NEW YORK, Aug. 3, 2011 /PRNewswire/ -- Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, welcomed 130 academically outstanding high school students to witness a live robotic prostatectomy procedure.
NEW YORK, July 30, 2011 /PRNewswire/ -- When Anyang' Nyong'o, Medical Services Minister of Kenya, returned cancer-free to his native land in March of this year, he made a commitment to the people of Kenya. "My experience is a wake-up call for us in Kenya," he proclaimed.
NEW YORK, July 27, 2011 /PRNewswire/ -- For men facing radical prostatectomy procedures, elimination of their prostate cancer is not their only concern. In fact, a large number of these men list damage to their sexual potency and urinary continence among their biggest fears.
NEW YORK, July 18, 2011 /PRNewswire/ -- Just one year after the FDA approved Provenge, an immunotherapy for treating advanced prostate cancer, Medicare announced that they will continue to pay in full for Provenge when used in accordance with label indications.
NEW YORK, June 18, 2011 /PRNewswire/ -- June is Men's Health Month, with June 13-19 being International Men's Health Week that leads up and includes Father's Day on June 19th. Prostate cancer treatment expert Dr.
NEW YORK, June 8, 2011 /PRNewswire/ -- The rapid adoption of robotic prostatectomy in the US is leading more men to choose surgery as their primary treatment for prostate cancer, according to a study presented at the annual American Urological Association meeting and co-authored by Dr.
NEW YORK, May 26, 2011 /PRNewswire/ -- A new prostate cancer study published in the New England Journal of Medicine comparing surgical treatment to "watchful waiting" revealed important findings for patients newly diagnosed with prostate cancer and currently debating their treatment options.
NEW YORK, May 9, 2011 /PRNewswire/ -- Robotic prostatectomy and prostate cancer treatment expert Dr.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.